Tulip Mediworld Profile
Key Indicators
- Authorised Capital ₹ 60.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 54.34 Cr
as on 15-11-2024
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 74.00 Cr
as on 15-11-2024
- Revenue %
(FY 2023)
- Profit -27.73%
(FY 2023)
- Ebitda -27.73%
(FY 2023)
- Net Worth 39.76%
(FY 2023)
- Total Assets 166.65%
(FY 2023)
About Tulip Mediworld
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 60.00 Cr and a paid-up capital of Rs 54.34 Cr.
The company currently has active open charges totaling ₹74.00 Cr.
The Key Managerial Personnel (KMP) at Tulip Mediworld Private Limited India is Anisha Agarwala as COMPANY SECRETARY. Apurba Sarma, Sneha Agarwal, Mamoni Deka, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300AS2021PTC021402
- Company No.
021402
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 May 2021
- Date of AGM
12 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Kamrup, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tulip Mediworld?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Apurba Sarma  | Managing Director | 31-May-2021 | Current |
| Anisha Agarwala | Company Secretary | 16-May-2022 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sneha Agarwal | Director | 08-Jul-2022 | Current |
| Mamoni Deka | Director | 31-May-2021 | Current |
| Hiramoni Sarma | Director | 31-May-2021 | Current |
Financial Performance of Tulip Mediworld.
Tulip Mediworld Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 27.73% decrease in profit. The company's net worth Soared by an impressive increase of 39.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tulip Mediworld?
In 2023, Tulip Mediworld had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Apr 2022 | ₹74.00 Cr | Open |
How Many Employees Work at Tulip Mediworld?
Tulip Mediworld has a workforce of 0 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tulip Mediworld, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tulip Mediworld's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
